APA (7th ed.) Citation

Fedele, P., Rizzo, A., Landriscina, M., Stucci, S. L., Morritti, M., Giuliani, F., . . . Gadaleta-Caldarola, G. (2025). BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis. Journal of Clinical Medicine, 14(24), 8854. https://doi.org/10.3390/jcm14248854

Chicago Style (17th ed.) Citation

Fedele, Palma, et al. "BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis." Journal of Clinical Medicine 14, no. 24 (2025): 8854. https://doi.org/10.3390/jcm14248854.

MLA (9th ed.) Citation

Fedele, Palma, et al. "BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis." Journal of Clinical Medicine, vol. 14, no. 24, 2025, p. 8854, https://doi.org/10.3390/jcm14248854.